Latka logo
Generate Biomedicines logo

Generate Biomedicinesrevenue & funding

Data Science and Machine Learning PlatformsCambridge, MassachusettsFounded 2018CEO Michael Nally

Public company

Generate Biomedicines is a biotechnology company founded in 2018 and headquartered in Cambridge, Massachusetts. It specializes in using machine learning and biological engineering to create biomedicines.

Annual revenue
$31.9M
Dec 2025 · SEC filing+56% YoY
Employees
317
Nov 2025

Generate Biomedicines revenue

Generate Biomedicines' annual revenue was $31.9M in December 2025 (SEC filing). That is up 56% from $20.5M a year earlier.

$0
$10M
$20M
$30M
$0
–
$20.5M
$31.9M
20182019–2320242025
ReportedFounded 2018 at $0; every reading has its own bar
All 2 revenue readings, with sources
As ofRevenueSource
Dec 2024$20.5MSEC filing
Dec 2025$31.9MSEC filing

Generate Biomedicines funding rounds & investors

Generate Biomedicines has raised $370M in one round: a Series C in November 2024.

Rounds before the IPO
DateRoundRaisedValuation
Nov 2024Series C$370M$2B
Total raised$370M

Generate Biomedicines CEO, founders & employees

Michael Nally founded Generate Biomedicines in 2018 and runs it as CEO. Generate Biomedicines has 317 employees (November 2025, LinkedIn).

0
100
200
300
317
2025
ReportedOne figure per year; a reported figure wins over an estimate

Generate Biomedicines FAQ

What is Generate Biomedicines' revenue?

Generate Biomedicines' annual revenue was $31.9M in December 2025, according to an SEC filing.

Is Generate Biomedicines publicly traded?

Yes. Generate Biomedicines is a public company.

How much funding has Generate Biomedicines raised?

Generate Biomedicines raised $370M in one funding round: a Series C in November 2024.

How many employees does Generate Biomedicines have?

Generate Biomedicines has 317 employees as of November 2025, according to LinkedIn.

Who is the CEO of Generate Biomedicines?

Michael Nally is the CEO of Generate Biomedicines and founded the company in 2018.

Who founded Generate Biomedicines?

Michael Nally founded Generate Biomedicines in 2018.

How this page is sourced

3 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Nov 16, 2026Data disclaimerReport a correctionClaim this profileRun Generate Biomedicines? Join the podcast